Phase 2 study of PTC299 in glioblastoma multiforme (IND 71,033)
Ended Cooperative Agreement Awarded Last action
- Award ID
- R01FD003713
- Recipient
-
PTC Therapeutics, Inc. UEI LH7QEHP9V7W1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $4,351
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Place of performance
- South Plainfield, NJ 07080, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$395,391 | |
| Original award | $399,742 |
Quick answers
Who received award R01FD003713?
R01FD003713 was awarded to PTC Therapeutics, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 10, 2010.
How much is award R01FD003713 worth?
$4,351 has been obligated on R01FD003713.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award